Join
Live feed
·
PRReleasevia Quantisnow
TFF Pharmaceuticals Inc. logo

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

ByQuantisnow·Wall Street's wire, on your screen.
TFFP· TFF Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TFFP (TFF Pharmaceuticals Inc.) and more on Quantisnow.